He aha ka Ombitasvir-Paritaprevir-Ritonavir-a-me-Dasabuvir: Nā hoʻohana, ka nui o ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

ʻO Ombitasvir-paritaprevir-ritonavir-a-me-dasabuvir he lāʻau hui pū i hoʻolālā ʻia e mālama i ka maʻi hepatitis C virus (HCV). Ke hana pū nei kēia hui ʻana o nā lāʻau lapaʻau ʻehā ma ke ʻano he hui ikaika e pale i ka maʻi mai ka hoʻonui ʻana i loko o kou kino, e hāʻawi ana i kou ate i ka manawa e hoʻōla ai mai ka pōʻino i hana ʻia e ka maʻi hepatitis C mau.

Inā ua ʻike ʻia ʻoe a i ʻole kekahi āu e mālama nei me ka hepatitis C, hiki iā ʻoe ke manaʻo nui ʻia e ka inoa paʻakikī o kēia lāʻau. ʻO ka mea maikaʻi, ua kōkua kēia lapaʻau i nā tausani o nā kānaka e hoʻomaʻemaʻe i ka maʻi mai ko lākou kino a hoʻihoʻi i ko lākou olakino.

He aha ka Ombitasvir-Paritaprevir-Ritonavir-a-me-Dasabuvir?

ʻO kēia lāʻau lapaʻau he hui paʻa o nā lāʻau antiviral ʻehā like ʻole e hana pū ana e hakakā i ka hepatitis C. He hana kūikawā ko kēlā me kēia mea i ka pale ʻana i ka maʻi mai ka hana hou ʻana a me ka laha ʻana i loko o kou kino.

E noʻonoʻo e like me kahi hui kūikawā kahi i loaʻa i kēlā me kēia lālā nā mākau kūikawā. Hoʻopaʻa ʻo Ombitasvir i hoʻokahi protein e pono ai ka maʻi e ola, hoʻōki ʻo paritaprevir i kekahi protein viral koʻikoʻi, kōkua ʻo ritonavir i nā lāʻau ʻē aʻe e hana maikaʻi a lōʻihi i loko o kāu ʻōnaehana, a pale ʻo dasabuvir i ka maʻi mai ka hana ʻana i nā kope o ia iho.

ʻOi aku ka maikaʻi o kēia ala hui ma mua o ka hoʻohana ʻana i kekahi lāʻau hoʻokahi wale nō. Hele mai ka lāʻau lapaʻau i ke ʻano papa a lawe ʻia ma ke ʻano he ʻāpana o kahi hoʻoponopono lapaʻau hepatitis C piha.

No ke aha e hoʻohana ʻia ai ka Ombitasvir-Paritaprevir-Ritonavir-a-me-Dasabuvir?

Hoʻohana nui ʻia kēia lāʻau lapaʻau e mālama i ka maʻi hepatitis C virus mau i nā pākeke. He mea kūpono ia i kekahi mau ʻano o ka hepatitis C, ʻoi aku ka genotype 1, ʻo ia ke ʻano maʻamau i loaʻa ma ʻAmelika Hui Pū ʻIa.

Na kāu kauka e hoʻoholo inā kūpono kēia lāʻau lapaʻau iā ʻoe ma muli o nā kumu he nui. Aia kēia mau mea i ke ʻano kikoʻī o ka hepatitis C āu i loaʻa ai, inā ua hoʻāʻo ʻoe i nā lāʻau lapaʻau ʻē aʻe ma mua, ke kūlana o kou ate i kēia manawa, a me kou olakino holoʻokoʻa.

Hoʻohana pinepine ʻia ka lāʻau lapaʻau me ka ribavirin, kekahi lāʻau antiviral, e hana i kahi ala lapaʻau ʻoi aku ka piha. Ua hōʻike kēia hui pū ʻana i nā hopena maikaʻi loa i nā haʻawina lapaʻau, me ka nui o nā maʻi e loaʻa ana i ka mea a nā kauka e kapa ai he

Hele mai ka lāʻau lapaʻau ma ke ʻano he pūʻolo hui pū me nā papa like ʻole. E lawe ʻoe i ʻelua papa i ke kakahiaka me ka meaʻai - hoʻokahi i loaʻa ka ombitasvir, paritaprevir, a me ritonavir, a ʻo kekahi i loaʻa ka dasabuvir.

He mea nui e lawe i kāu mau lāʻau i ka manawa like i kēlā me kēia lā e mālama i nā pae paʻa o ka lāʻau i loko o kou kahe koko. E koho i kahi manawa e hana maikaʻi me kāu hana maʻamau i kēlā me kēia lā, e like me ka ʻaina kakahiaka, i ʻole ʻoe e poina.

Mai ʻoki, wāwahi, a nau paha i nā papa. E ale iā lākou me ka wai a i ʻole kekahi mea inu. Kōkua ka uhi ʻana ma nā papa e hōʻoia i ka hoʻokuʻu pono ʻana o ka lāʻau i loko o kāu ʻōnaehana digestive.

Pehea ka lōʻihi e lawe ai au i ka Ombitasvir-Paritaprevir-Ritonavir-and-Dasabuvir?

Lawe ka hapa nui o nā kānaka i kēia lāʻau lapaʻau no 12 pule, ʻoiai e hilinaʻi ka lōʻihi o kāu lapaʻau i nā mea he nui e pili ana i kou kūlana. E hoʻoholo kāu kauka i ka lōʻihi pololei e pili ana i kāu genotype hepatitis C, ke kūlana o ke ake, a me ka mōʻaukala lapaʻau.

Pono paha kekahi poʻe maʻi i ka lapaʻau no 24 pule, ʻoiai inā he mau mea pilikia ko lākou a i ʻole i hoʻāʻo i nā lapaʻau hepatitis C ʻē aʻe ma mua. E nānā kāu kauka i kou holomua i ka wā o ka lapaʻau me nā hoʻokolohua koko maʻamau.

He mea nui e hoʻopau i ka papa lapaʻau piha inā hoʻomaka ʻoe e maikaʻi. Hiki nō ke loaʻa ka maʻi i loko o kou kino inā maikaʻi ʻoe, a ʻo ka hoʻōki ʻana i ka lapaʻau ma mua hiki ke ʻae iā ia e hoʻi a hiki ke kūʻē i ka lāʻau.

I ka wā o ka lapaʻau, e loaʻa iā ʻoe nā loiloi maʻamau e nānā i ka maikaʻi o ka hana ʻana o ka lāʻau a e nānā i nā hopena ʻaoʻao. E nānā pū kāu kauka i kāu hana ate a me nā pae ukana viral.

He aha nā hopena ʻaoʻao o Ombitasvir-Paritaprevir-Ritonavir-and-Dasabuvir?

E like me nā lāʻau lapaʻau a pau, hiki i kēia hui ʻana ke hana i nā hopena ʻaoʻao, ʻoiai he nui ka poʻe e ʻae maikaʻi ana. ʻO nā hopena ʻaoʻao maʻamau he maʻalahi a hiki ke mālama ʻia me ka mālama kūpono a me ka nānā ʻana.

Eia nā hopena ʻaoʻao āu e ʻike ai, me ka noʻonoʻo ʻana ʻaʻole e loaʻa i nā kānaka a pau kēia mau hopena:

ʻO nā hopena ʻaoʻao maʻamau e komo pū ana:

• Luhi a i ʻole ka luhi ma mua o ka maʻamau
• Nausea a i ʻole ka ʻoluʻolu o ka ʻōpū
• Poʻo
• He paʻakikī ka hiamoe a i ʻole nā loli i nā ʻano hiamoe
• ʻO ka ʻili ʻana a i ʻole ka ʻili maʻalahi
• Nawaliwali a i ʻole ka maikaʻi ʻole

ʻO nā hopena ʻaoʻao liʻiliʻi akā ʻoi aku ka koʻikoʻi e komo pū ana:

• Nā hopena ʻili koʻikoʻi a i ʻole ka ʻili ākea
• Nā pilikia ate nui a i ʻole ka hōʻino ʻana i ka hana ate
• Luhi nui e keakea ana i nā hana o kēlā me kēia lā
• Nausea mau a i ʻole ka luaʻi
• Melemele o ka ʻili a i ʻole nā maka (jaundice)
• Mimi ʻeleʻele a i ʻole nā ʻōpala palupalu

ʻO ka hapa nui o nā hopena ʻaoʻao he manawa pōkole a hoʻomaikaʻi i ka wā e hoʻoponopono ai kou kino i ka lāʻau lapaʻau. Eia naʻe, he mea nui e noho kokoke i kāu hui mālama ola i hiki iā lākou ke kōkua i ka mālama ʻana i nā hopohopo e kū mai ana.

ʻO wai ka mea pono ʻole e lawe iā Ombitasvir-Paritaprevir-Ritonavir-and-Dasabuvir?

ʻAʻole kūpono kēia lāʻau lapaʻau no nā mea a pau, a e loiloi pono kāu kauka inā ʻo ia ke koho kūpono no kāu kūlana kikoʻī. Hiki i kekahi mau maʻi olakino a me nā lāʻau lapaʻau ke hoʻolilo i kēia lāʻau lapaʻau i mea palekana ʻole a i ʻole ka maikaʻi ʻole.

ʻAʻole pono ʻoe e lawe i kēia lāʻau lapaʻau inā loaʻa iā ʻoe nā pilikia ate mai ka maʻi hepatitis C. Hiki i ka lāʻau lapaʻau ke hoʻokau i ke koʻikoʻi hou i kou ate, hiki ke pilikia inā ua hoʻopilikia nui ʻia kāu hana ate.

Pono nā kānaka e lawe ana i kekahi mau lāʻau lapaʻau e pale pū i kēia hui pū. Hiki iā ia ke launa pū me nā lāʻau lapaʻau maʻamau he nui, me kekahi mau lāʻau lapaʻau puʻuwai, nā lāʻau lapaʻau hopu, a me nā mea e kāohi ai i ka ʻōnaehana pale i hoʻohana ʻia ma hope o ka hoʻololi ʻana i nā ʻōkana.

Pono nā wāhine e hāpai ana a i ʻole e hoʻolālā ana e hāpai e kūkākūkā i nā lāʻau lapaʻau ʻē aʻe me kā lākou kauka. ʻAʻole i hoʻokumu ʻia ka palekana o kēia lāʻau lapaʻau i ka wā hāpai, a hiki i kekahi mau mea ke hōʻike i nā pilikia i nā pēpē e ulu ana.

Inā loaʻa iā ʻoe ka HIV me ka hepatitis C, pono ʻoe e noʻonoʻo kūikawā. ʻOiai hiki ke mālama ʻia, pono kāu kauka e hoʻonohonoho pono i kāu mau lāʻau HIV me kēia lāʻau lapaʻau hepatitis C e pale aku i nā pilina pōʻino.

Inoa Brand Ombitasvir-Paritaprevir-Ritonavir-and-Dasabuvir

Kūʻai ʻia kēia hui pū ʻana o nā lāʻau lapaʻau ma lalo o ka inoa brand Viekira Pak ma ʻAmelika Hui Pū ʻIa. Hoʻomaʻamaʻa ka inoa brand i ka ʻike a me ke kūkākūkā ʻana me kāu hui mālama ola, ka mea kūʻai lāʻau, a me ka hui ʻinikua.

Hele mai ʻo Viekira Pak ma ke ʻano he pūʻolo lāʻau i kēlā me kēia lā i loaʻa nā papa pololei āu e pono ai no kēlā me kēia lā o ka mālama ʻana. Kōkua kēia ʻōnaehana hoʻopili e hōʻoia e lawe ʻoe i ka hui pū ʻana o nā lāʻau lapaʻau i ka manawa kūpono.

Loaʻa i kekahi mau hoʻolālā ʻinikua nā koi kikoʻī no ka uhi ʻana i nā lāʻau lapaʻau inoa brand. Hiki i ke keʻena o kāu kauka ke kōkua iā ʻoe e hoʻokele i nā kaʻina hana ʻae ʻinikua a hiki ke hāʻawi i ka ʻike e pili ana i nā papahana kōkua maʻi inā he hopohopo ke kumukūʻai.

Nā Koho ʻē aʻe ʻo Ombitasvir-Paritaprevir-Ritonavir-and-Dasabuvir

Loaʻa nā lāʻau lapaʻau hepatitis C ʻē aʻe inā ʻaʻole kūpono kēia lāʻau lapaʻau iā ʻoe. Hiki i kāu kauka ke ʻōlelo i nā koho ʻē aʻe e pili ana i kāu genotype kikoʻī, ke kūlana o ke ake, a me nā mea olakino ʻē aʻe.

ʻO nā hui antiviral hana pololei ʻē aʻe e komo pū ana i nā ʻōnaehana i hoʻokumu ʻia i ka sofosbuvir, e hana ʻokoʻa ana akā he mea maikaʻi loa nō hoʻi. He kūpono paha kēia mau koho ʻē aʻe no ka poʻe me kekahi mau ʻano o ka hepatitis C a i ʻole ka poʻe hiki ʻole ke lawe i ka hui ombitasvir.

ʻO Glecaprevir-pibrentasvir kekahi koho ʻē aʻe e hana ana i nā ʻano hepatitis C he nui a he pōkole ka lōʻihi o ka mālama ʻana no kekahi mau maʻi. E noʻonoʻo kāu kauka i nā mea e like me kāu mōʻaukala lapaʻau a me ka hana o ka puʻupaʻa i ke koho ʻana ma waena o nā koho.

Aia ke koho o ka lapaʻau i nā mea pilikino he nui. ʻO ka mea e hana maikaʻi loa no kekahi kanaka ʻaʻole paha ia he mea kūpono no kekahi, no laila he mea nui e hana kokoke me kahi mea mālama ola i ʻike i ka mālama ʻana i ka hepatitis C.

Ua ʻoi aku ka maikaʻi o Ombitasvir-Paritaprevir-Ritonavir-and-Dasabuvir ma mua o Sofosbuvir?

He mea maikaʻi loa nā lāʻau lapaʻau ʻelua no ka mālama ʻana i ka hepatitis C, akā hana lākou i nā mea like ʻole a he mea kūpono paha no nā maʻi like ʻole. Aia ke koho ma waena o lākou i kāu kūlana kikoʻī ma mua o ka mea i ʻoi aku ka maikaʻi ma mua o kekahi.

He mea maikaʻi loa ʻo Ombitasvir-paritaprevir-ritonavir-and-dasabuvir no ka hepatitis C genotype 1, ʻoiai hiki i nā lāʻau lapaʻau i hoʻokumu ʻia i ka sofosbuvir ke hana i nā genotypes he nui. Inā loaʻa iā ʻoe ka genotype 1 hepatitis C me ka hana maʻamau o ka puʻupaʻa, hiki i nā koho ʻelua ke koho maikaʻi loa.

Makemake ʻia nā ʻōnaehana i hoʻokumu ʻia i ka Sofosbuvir inā loaʻa iā ʻoe nā pilikia o ka puʻupaʻa, no ka mea, maʻalahi lākou i nā puʻupaʻa. Loaʻa pū kekahi iā lākou nā pilina lāʻau liʻiliʻi, he mea nui paha inā ʻoe e lawe i nā lāʻau he nui.

Hiki ke koho ʻia ka hui ombitasvir inā loaʻa iā ʻoe nā manaʻo inikua kikoʻī a i ʻole inā he nui ka ʻike o kāu kauka me kēia ʻōnaehana. Loaʻa i nā lāʻau lapaʻau ʻelua nā helu hoʻōla like ke hoʻohana pono ʻia.

Nā Nīnau i Nīnau Pinepine ʻia e pili ana iā Ombitasvir-Paritaprevir-Ritonavir-and-Dasabuvir

He Palekana anei ʻo Ombitasvir-Paritaprevir-Ritonavir-a-me-Dasabuvir no ka poʻe me ka maʻi diabetes?

ʻAe, palekana maʻamau kēia lāʻau lapaʻau no ka poʻe me ka maʻi diabetes, akā pono e nānā pono. Hiki i ka hui ke hoʻopilikia i nā pae kōpaʻa koko, no laila e makemake kāu kauka e nānā pono i kāu mālama ʻana i ka maʻi diabetes i ka wā o ka mālama ʻana.

Pono paha ʻoe e nānā pinepine i kou kōpaʻa koko i ka wā e lawe ana i kēia lāʻau lapaʻau. Loaʻa i kekahi poʻe nā loli i kā lākou ʻano kōpaʻa koko, ʻoiai hiki ke mālama ʻia kēia mau hopena me ka nānā pono ʻana a me nā hoʻoponopono ʻana i nā lāʻau lapaʻau diabetes.

He mea nui e haʻi i kāu kauka e pili ana i kāu mau lāʻau lapaʻau diabetes a pau ma mua o ka hoʻomaka ʻana i ka mālama ʻana. Hiki i kekahi mau lāʻau diabetes ke launa pū me kēia lāʻau lapaʻau hepatitis C, e koi ana i nā hoʻoponopono ʻana i ka mahele a i ʻole nā lāʻau lapaʻau ʻē aʻe.

He aha kaʻu e hana ai inā ua hoʻohana hewa au i ka nui o Ombitasvir-Paritaprevir-Ritonavir-a-me-Dasabuvir?

Inā lawe hewa ʻoe i ka nui ma mua o kāu mahele i kauoha ʻia, e kelepona koke i kāu kauka a i ʻole ka mea kūʻai lāʻau lapaʻau no ke alakaʻi. ʻOiai he kakaikahi nā hopena overdose koʻikoʻi, he mea nui e kiʻi i ka ʻōlelo aʻo ʻoihana e pili ana i ka mea e hana ai.

Mai ho'āʻo e

Inā ua hala ma mua o 12 hola mai kou manawa maʻamau e lawe ai i ka lāʻau, e lele i ka lāʻau i hala a e lawe i kāu lāʻau aʻe i ka manawa maʻamau. Mai lawe i ʻelua lāʻau i ka manawa hoʻokahi e pani ai i ka lāʻau i hala, no ka mea, hiki i kēia ke hoʻonui i kou pilikia o nā hopena ʻaoʻao.

E hoʻāʻo e hoʻonohonoho i nā mea hoʻomanaʻo e kōkua iā ʻoe e hoʻomanaʻo i kāu lāʻau i kēlā me kēia lā. Hiki iā ʻoe ke hoʻohana i ka uaki kelepona, ka mea hoʻonohonoho lāʻau, a i ʻole ka polokalamu lāʻau e kōkua i ka mālama ʻana i kāu papa manawa lāʻau i ka wā o ka mālama ʻana.

Iāhea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Ombitasvir-Paritaprevir-Ritonavir-and-Dasabuvir?

Pono ʻoe e hooki i ka lawe ʻana i kēia lāʻau i ka wā e haʻi aku ai kāu kauka iā ʻoe, ma hope o ka pau ʻana o ka papa hana lapaʻau i kauoha ʻia. Lawe ka hapa nui o nā kānaka i ka lāʻau no 12 pule, akā pono paha kekahi poʻe i 24 pule ma muli o ko lākou kūlana.

E nānā kāu kauka i kou holomua me nā hoʻokolohua koko maʻamau e nānā i kāu pae viral load. ʻOiai inā ʻaʻole hiki ke ʻike ʻia ka maʻi i ka wā mua o ka mālama ʻana, he mea nui e hoʻopau i ka papa hana piha e pale ai i ka hoʻi ʻana mai o ka maʻi.

Ma hope o kou pau ʻana i ka mālama ʻana, e hoʻomau kāu kauka i ka nānā ʻana iā ʻoe no kekahi mau mahina e hōʻoia i ka noho ʻana o ka maʻi i ka hiki ʻole ke ʻike ʻia. Kōkua kēia manawa hahai i ka hōʻoia ʻana ua holomua ka mālama ʻana a ua hoʻomaʻemaʻe mau ʻia ka maʻi mai kou ʻōnaehana.

Hiki iaʻu ke inu i ka waiʻona i ka wā e lawe ana iā Ombitasvir-Paritaprevir-Ritonavir-and-Dasabuvir?

ʻOi aku ka maikaʻi e pale loa i ka waiʻona i ka wā e lawe ana i kēia lāʻau. Hiki i ka waiʻona ke hoʻokau i ke koʻikoʻi hou i kou ate, e hana ikaika ana e hana i ka lāʻau a hoʻōla mai ka pōʻino hepatitis C.

Pono kou ate i kona ikehu a pau e kālele ana i ka hoʻōla i ka wā o ka mālama ʻana. ʻO ka hoʻohui ʻana i ka waiʻona i ka hui hiki ke hoʻolohi i ka hoʻōla a hoʻonui i ka pilikia o nā hopena ʻaoʻao e pili ana i ka ate mai ka lāʻau.

Inā he hopohopo kou no ka hoʻohana ʻana i ka waiʻona a i ʻole e pono ai ke kākoʻo i ka pale ʻana i ka waiʻona i ka wā o ka mālama ʻana, e kūkākūkā ākea me kāu hui mālama ola. Hiki iā lākou ke hāʻawi i nā kumuwaiwai a me ke kākoʻo e kōkua iā ʻoe e mālama i nā hana waiʻona ʻole i kēia manawa mālama nui.